期刊文献+

肝细胞癌中Survivin的表达与微血管密度的关系 被引量:1

下载PDF
导出
摘要 目的研究Survivin在肝细胞癌(HCC)组织中的表达情况及其与微血管密度(MVD)的关系。方法应用ABC免疫组化法检测40例HCC标本组织中Survivin的表达情况和MVD,并将检测结果与HCC的临床病例特征进行统计分析。结果①Survivin在40例HCC癌组织和癌旁组织中的阳性表达率分别是65.0%、27.5%,有显著差异(χ2=10.316,P=0.001);表达评分分别是(2.45±1.96)、(1.35±1.64),有显著差异(t=3.075,P=0.004);癌组织中MVD(66.42±11.89)显著高于癌旁组织(36.56±7.39)(t=14.183,P=0.000)。②除伴转移病例癌组织中MVD(72.57±11.26)显著高于无转移病例(64.25±12.11)(t=2.121,P=0.04)外,Survivin表达情况及MVD与HCC其他主要临床病理特征之间均无明显关系。③HCC癌组织中Survivin的阳性表达评分与MVD呈正相关(r=0.327,P=0.039)。结论 Survivin在HCC的发生、进展中起着重要作用,并与HCC的血管生成密切相关。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第12期3272-3273,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献10

  • 1Rykala J,Przybylowska K,Majsterek I. Angiogenesis markers quan-tification in breast cancer and their correlation with clinicopathological prognostic variables[J].Pathology Oncology Research,2011,(04):809-817. 被引量:1
  • 2Kappler M,Kotzsch M,Bartel F. Elevated expression level of sur-vivin protein in soft-tissue sarcomas is a strong independent predictor of survival[J].Clinical Cancer Research,2003,(03):1098-1104. 被引量:1
  • 3Weidner N,Carroll PR,Flax J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma[J].AMERICAN JOURNAL OF PATHOLOGY,1993,(02):401-409. 被引量:1
  • 4向志钢,杨竹林,黄建军.原发性肝癌组织中RANTES的表达与微血管密度的关系[J].上海交通大学学报(医学版),2010,30(2):222-224. 被引量:3
  • 5Ryan BM,O'Donovan N,Duffy MJ. Survivin:a new target for anti-cancer therapy[J].Cancer Treatment Reviews,2009,(07):553-562. 被引量:1
  • 6刘伟,黄超,邢伟.大肠癌中Survivin和nm23-H1的表达及其联合检测的临床意义[J].第三军医大学学报,2011,33(19):2074-2076. 被引量:7
  • 7Baykara M,Akkus M,Yildiz R. Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma[J].Int Immunop-harmacol,2011,(12):2227-2231. 被引量:1
  • 8Li, Xiao-Dong,Luo, Wen-Jian,Yao, Xin.Preface[J].Journal of Computer Science & Technology,2008,23(1):1-1. 被引量:156
  • 9李金贵(综述),胡自力(审校).存活素基因与肿瘤的研究现状[J].国际检验医学杂志,2007,28(5):462-464. 被引量:9
  • 10Coma S,Noe V,Lavarino C. Use of siRNAs and antisense oligonu-cleotides against survivin RNA to inhibit steps leading to tumor angio-genesis[J].OLIGONUCLEOTIDES,2004,(02):100-113. 被引量:1

二级参考文献31

  • 1元云飞,李锦清,李斌奎,张亚奇,李国辉.影响肝细胞肝癌切除术后长期生存的相关因素[J].中国实用外科杂志,2004,24(10):608-611. 被引量:9
  • 2Hai-Yan Tan,Jun Liu,Shan-Min Wu,He-Sheng Luo.Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma[J].World Journal of Gastroenterology,2005,11(30):4689-4692. 被引量:28
  • 3Popiela TJ, Sikora J, Klimek M, et al. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases[ J]. Neuro Endoetinol Lett, 2008, 29(4) : 443 -446. 被引量:1
  • 4Soria G, Yaal-Hahoshen N, Azenshtein E, et al. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions [J]. Cytokine, 2008, 44(1) : 191 -200. 被引量:1
  • 5Foote RL, Weidner N, Harris J, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505 [J]. Int J Radiat Oncol Biol Phys, 2005, 61 (3): 745 -753. 被引量:1
  • 6Sofia G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer[ J]. Cancer Lett, 2008, 267 (2) : 271 - 285. 被引量:1
  • 7Adler EP, l,emken CA, Katchen NS, et al. A dual role for tumorderived chemokine RANTES (CCL5)[J]. Immunol Lett, 2003, 90 (2-3): 187-194. 被引量:1
  • 8Azenshtein E, Luboshits G, Shina S, et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity[J]. Cancer Res, 2002, 62(4) : 1093 - 1102. 被引量:1
  • 9Bernardini G, Ribatti D, Spinetti G, et al. Analysis of the role of chemokines in angiogenesis [ J ]. J Immunol Methods, 2003, 273 (1-2): 83-101. 被引量:1
  • 10O'counor DS, Schechner JS, Adida C, et al. Control of apoptosis during angiogenesis by Survivin express in endothelial cell[J]. Am J Pathol,2000,156(2) :393-398. 被引量:1

共引文献171

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部